![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/11/ARD-266-is-a-Highly-Potent-AR-PROTAC-Degrader-2020-12-01.jpg)
In our cancer blog, we have introduced a large number of PROTACs. A1874 exhibits a nultin-based BRD4-degrading PROTAC. MT-802 shows…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/11/BETd-246-is-a-PROTAC-Based-BET-BRD-Degrader-2020-11-12.jpg)
In previous blogs, we have introduced a lot of PROTAC based degraders, including TD-428, HJB97, A1874, etc. Coincidentally most of…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/05/J22352-PROTAC-Like-Highly-Selective-HDAC6-Inhibitor-Enhances-Antitumor-Immunity-in-Glioblastoma-2019-05-15.jpg)
Glioblastomas (also called GBM) are malignant Grade IV tumors, where a large portion of tumor cells are reproducing and dividing at…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/04/MS4078-Immune-Response-NPM-ALK-PROTAC-Cancer-Immunotherapy-2019-04-14.jpg)
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase. ALK belongs to the insulin receptor kinase subfamily. Nucleophosmin (NPM)-ALK is…